These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 8377008

  • 1. Uptake of 1-methyl-4-phenylpyridinium and dopamine in the mouse brain cell nuclei.
    Buu NT.
    J Neurochem; 1993 Oct; 61(4):1557-60. PubMed ID: 8377008
    [Abstract] [Full Text] [Related]

  • 2. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 3. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH.
    Proc Natl Acad Sci U S A; 1985 Apr 08; 82(7):2173-7. PubMed ID: 3872460
    [Abstract] [Full Text] [Related]

  • 4. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K, Trevor AJ, Castagnoli N.
    Biochem Biophys Res Commun; 1985 May 16; 128(3):1228-32. PubMed ID: 3873939
    [Abstract] [Full Text] [Related]

  • 5. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S, Zuddas A, Kopin IJ, Barker JL, di Porzio U.
    J Neurochem; 1988 Jun 16; 50(6):1900-7. PubMed ID: 3259619
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of accumulation of the 1-methyl-4-phenylpyridinium species into mouse brain synaptosomes.
    Scotcher KP, Irwin I, DeLanney LE, Langston JW, Di Monte D.
    J Neurochem; 1991 May 16; 56(5):1602-7. PubMed ID: 2013755
    [Abstract] [Full Text] [Related]

  • 7. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F, Alessandrì MG, Torracca MT, Bassi L, Corsini GU.
    J Pharmacol Exp Ther; 1997 Oct 16; 283(1):100-7. PubMed ID: 9336313
    [Abstract] [Full Text] [Related]

  • 8. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes.
    Scotcher KP, Irwin I, DeLanney LE, Langston JW, Di Monte D.
    J Neurochem; 1990 Apr 16; 54(4):1295-301. PubMed ID: 2313288
    [Abstract] [Full Text] [Related]

  • 9. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A, Fascetti F, Corsini GU, Piccardi MP.
    Exp Neurol; 1994 May 16; 127(1):54-61. PubMed ID: 8200437
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reserpine induced intraneuronal dopamine oxidation: reversal by MPP+ action.
    Bagchi SP.
    Life Sci; 1991 May 16; 48(10):1007-13. PubMed ID: 1672033
    [Abstract] [Full Text] [Related]

  • 13. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
    Vyas I, Heikkila RE, Nicklas WJ.
    J Neurochem; 1986 May 16; 46(5):1501-7. PubMed ID: 3485701
    [Abstract] [Full Text] [Related]

  • 14. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Staal RG, Yang JM, Hait WN, Sonsalla PK.
    Brain Res; 2001 Aug 10; 910(1-2):116-25. PubMed ID: 11489261
    [Abstract] [Full Text] [Related]

  • 15. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS, Abell CW, Gessner W, Brossi A.
    FEBS Lett; 1985 Sep 23; 189(2):225-30. PubMed ID: 3876242
    [Abstract] [Full Text] [Related]

  • 16. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG, Hogan KA, Liang CL, German DC, Sonsalla PK.
    J Pharmacol Exp Ther; 2000 May 23; 293(2):329-35. PubMed ID: 10772999
    [Abstract] [Full Text] [Related]

  • 17. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G, Nwanze E, Luthman J, Sundström E.
    Acta Physiol Scand; 1986 Oct 23; 128(2):187-94. PubMed ID: 3535380
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P, Nicklas WJ, Ofori S, Shen J, Mytilineou C.
    J Neurochem; 1989 Oct 23; 53(4):1149-55. PubMed ID: 2788714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.